¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"androgen insensitivity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® androgen ÇÑ±Û ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ
¼³¸í   
  ³²¼ºÀÇ ÀÌÂ÷ ¼ºÂ¡À» ³ªÅ¸³»°Ô Çϴ ȣ¸£¸ó. Å×½ºÅ佺Å×·Ð(testosterone), ¾Èµå·Î½ºÅ×·Ð(androsterone) µîÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • insensitivity
    ¹«°¨ÀÀ
  • androgen
    1. ³²¼ºÈ£¸£¸ó 2. ¾Èµå·Î°Õ
  • androgen binding protein
    ¾Èµå·Î°Õ°áÇմܹéÁú
  • androgen receptor
    ¾Èµå·Î°Õ¼ö¿ëü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • insensitivity
    ¹«°¨ÀÀ
  • androgen
    1.³²¼ºÈ£¸£¸ó, 2.¾Èµå·Î°Õ
  • total androgen
    ÃѾȵå·Î°Õ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • insensitivity
    ¹«°¨ÀÀ
  • androgen
    ¾Èµå·Î°Õ, ³²¼ºÈ£¸£¸ó
  • androgen receptor
    ¾Èµå·Î°Õ¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • androgen insensitivity
    ³²¼ºÈ£¸£¸ó ¹«°¨ÀÀ
  • androgen insensitivity syndrome
    ¾Èµå·Î°Õ( ³²¼ºÈ£¸£¸ó) ºÒ°¨¼º ÁõÈıº(ÝÕÊïàõ ñøý¦ÏØ)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ABP=> androgen-binding protein
    ¾Èµå·ÎÁ¨°áÇմܹé
  • androgen
    ¾Èµå·Î°Õ
  • androgen
    ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ, ¾Èµå·ÎÁ¨
  • androgen
    ¾Èµå·Î°Õ, ³²¼ºÈ£¸£¸ó(Ñûàõ¡­)
  • androgen
    ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ.
  • androgen antagonist
    ³²¼ºÈ£¸£¸ó ±æÇ×Á¦
  • androgen receptor
    ³²¼ºÈ£¸£¸ó ¼ö¿ëü
  • androgen therapy
    ³²¼ºÈ£¸£¸ó ¿ä¹ý
  • androgen, androgenic steroid
    ³²¼º(È­)È£¸£¸ó, ³²¼ºÈ­½ºÅ×·ÎÀ̵å.
  • androgen- binding protein
    ¸¸¼ºÈ£¸£¸ó °áÇմܹé
  • androgen-resistance syndrome
    ³²¼ºÈ£¸£¸ó ³»¼º(ÀúÇ×)ÁõÈıº?
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • androgen insensitivity
    ³²¼ºÈ£¸£¸ó ¹«°¨ÀÀ
  • androgen insensitivity syndrome
    ¾Èµå·Î°Õ( ³²¼ºÈ£¸£¸ó) ºÒ°¨¼º ÁõÈıº(ÝÕÊïàõ ñøý¦ÏØ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • androgen
    ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ, ¾Èµå·ÎÁ¨
  • androgen
    ¾Èµå·Î°Õ, ³²¼ºÈ£¸£¸ó(Ñûàõ¡­)
  • androgen
    ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ.
  • androgen
    ¾Èµå·Î°Õ
  • androgen antagonist
    ³²¼ºÈ£¸£¸ó ±æÇ×Á¦
  • androgen receptor
    ³²¼ºÈ£¸£¸ó ¼ö¿ëü
  • androgen therapy
    ³²¼ºÈ£¸£¸ó ¿ä¹ý
  • androgen, androgenic steroid
    ³²¼º(È­)È£¸£¸ó, ³²¼ºÈ­½ºÅ×·ÎÀ̵å.
  • androgen- binding protein
    ¸¸¼ºÈ£¸£¸ó °áÇմܹé
  • androgen-resistance syndrome
    ³²¼ºÈ£¸£¸ó ³»¼º(ÀúÇ×)ÁõÈıº?
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • androgen
    ¾Èµå·ÎÀü
  • androgen-binding protein
    ¾Èµå·ÎÀü°áÇÕ(Ì¿ùê) ´Ü¹éÁú(Ó±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • androgen
    ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AIS Abbreviated Injury Scale; amniotic infection syndrome; androgen insensitivity syndrome; anterior int...
CAI cellular adaptive immunotherapy; complete androgen insensitivity; computer-assisted instruction
CAIS complete androgen insensitivity syndrome
PAIS partial androgen insensitivity syndrome; phosphoribosylaminoimidazole synthetase; psychosocial adjus...
HI half-scan with interpolation; head injury; health insurance; hearing impaired; heart infusion; hemag...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AIS Androgen Insensitivity Syndrome
CAIS Complete Androgen Insensitivity Syndrome
CIPA Congenital Insensitivity to Pain with Anhidrosis
AA Adrenal androgen
A Androgen
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • androgen insensitivity syndrome
    ¾Èµå·Î°Õ ºÒ°¨¼º ÁõÈıº
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • androgen insensitivity syndrome
    ¾Èµå·Î°Õ ºÒ°¨¼º ÁõÈıº
  • androgen
    ³²¼º È£¸£¸ó, ¾Èµå·Î°Õ
    1. ³²¼ºÈ­ ÀÛ¿ëÀ» °¡Áø ¹°Áú. 2. ³²¼º È£¸£¸óÀ» ÅëÅо ºÎ¸£´Â À̸§. °íȯ¿¡¼­ ºÐºñµÇ´Â ³²¼º È£¸£¸óÀ¸·Î´Â testosterone, dihydrotestosterone ¹× androstenedion µîÀÌ ÀÖ´Ù. ÀÌÁß¿¡¼­µµ testosteroneÀÇ ºÐºñ·®ÀÌ °¡Àå ¸¹°í ³²¼º È£¸£¸óÀÇ È¿´Éµµ °¡Àå °­ÇÏ´Ù.
  • androgen binding protein
    ³²¼º È£¸£¸ó °áÇÕ ´Ü¹é
  • androgen resistance syndrome
    ³²¼º È£¸£¸ó ³»¼º ÁõÈıº, ³²¼º È£¸£¸ó ÀúÇ× ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
pain insensitivity, congenital Absence of sensibility to pain or inability to feel pain. The condition is present at birth.
(12 Dec 1998)
congenital insensitivity to pain <radiology> Autosomal recessive, neuropathic joints, micro- and macrofractures, epiphyseal separation, osteomyelitis (mandible, fingers, toes) Differential diagnosis: congenital insensitivity to pain with anhidrosis (autosomal recessive), hereditary sensory radicular neuropathy (autosomal recessive), congenital sensory neuropathy (autosomal dominant), familial dysautonomia (autosomal recessive), Lesch-Nyhan syndrome (X recessive)
(12 Dec 1998)
adrenal androgen Any androgenic hormone of adrenocortical origin; e.g., dehydroepiandrosterone (and its sulfate), androstenedione, 11b-hydroxyandrostenedione.
(05 Mar 2000)
adrenal androgen-stimulating hormone A putative pituitary hormone that may be responsible for increased secretion of adrenal androgens at the time of puberty.
(05 Mar 2000)
androgen <endocrinology> General term for any male sex hormone in vertebrates. Androgens may be used in patients with breast cancer to treat recurrence of the disease.
(14 May 1997)
androgen antagonists Compounds which inhibit or antagonise the biosynthesis or actions of androgens.
(12 Dec 1998)
androgen binding protein A protein secreted by testicular Sertoli cells along with inhibin and mullerian inhibiting substance. Androgen binding protein probably maintains a high concentration of androgen in the seminiferous tubules.
(05 Mar 2000)
androgen-binding proteins Carrier proteins produced in the sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. Participate in the transport of androgens; include also synthetic androgens binding proteins.
(12 Dec 1998)
androgen-dependent secretory protease <enzyme> Glycoprotein from dog prostate; hydrolyzes arginine and lysine-containing amide and ester protease substrates
Registry number: EC 3.4.99.-
Synonym: ads-protease
(26 Jun 1999)
androgen resistance syndromes A class of disorders associated with 5a-steroid reductase deficiency, testicular feminization, and related disorders.
Compare: steroid 5a-reductase, Reifenstein's syndrome, infertile male syndrome, testicular feminization syndrome.
(05 Mar 2000)
androgen unit The androgenic activity of 100 ug (0.1 mg) of crystalline androsterone as assayed by the comb growth response in capons.
(05 Mar 2000)
receptors, androgen Proteins, generally found in the cytoplasm, that specifically bind androgens and mediate their cellular actions. The complex of the androgen and receptor migrates to the nucleus where it induces transcription of specific segments of DNA.
(12 Dec 1998)
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 1 ÆäÀÌÁö: 1
  • Androgen insensitivity syndrome - »õâ
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
androgen insensitivity syndrome Androgen insensitivity syndrome (AIS) is a set of disorders of sexual differentiation that results from mutations of the gene encoding the androgen receptor. It has also been called androgen resistance in the medical literature. The nature of the resulting problem varies according to the structure and sensitivity of the abnormal receptor. Most of the forms of AIS involve variable degrees of undervirilization and/or infertility in XY persons of either sex. ...
Ãâó: en.wikipedia.org/wiki/Androgen_insensitivity_syndr...
androgen insensitivity s. complete androgen resistance; see under resistance.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • androgen
    ¾Èµå·Î°Õ(³²¼º È£¸£¸ó)
  • insensitivity
    ¹«°¨°¢;µÐ°¨
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á